{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:31:08Z","timestamp":1790645468589,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006280","name":"Ministerio de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["SAF-26091-2011"],"award-info":[{"award-number":["SAF-26091-2011"]}],"id":[{"id":"10.13039\/501100006280","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","journals.elsevierhealth.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clnu.2016.05.010","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T18:28:57Z","timestamp":1464287337000},"page":"798-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer"],"prefix":"10.1016","volume":"36","author":[{"given":"Josep M.","family":"Argil\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnu.2016.05.010_bib1","article-title":"From inflammation to cancer","author":"Korniluk","year":"2016","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.clnu.2016.05.010_bib2","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1615\/CritRevOncog.v17.i3.30","article-title":"Counteracting inflammation: a promising therapy in cachexia","volume":"17","author":"Argiles","year":"2012","journal-title":"Crit Rev Oncog"},{"key":"10.1016\/j.clnu.2016.05.010_bib3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1097\/SPC.0000000000000017","article-title":"Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target","volume":"4","author":"Klein","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2016.05.010_bib4","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"The role of cytokines in cancer cachexia","volume":"4","author":"Argil\u00e9s","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2016.05.010_bib5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.2217\/fon.10.20","article-title":"Are tumoral factors responsible for host tissue wasting in cancer cachexia?","volume":"6","author":"Tisdale","year":"2010","journal-title":"Future Oncol"},{"key":"10.1016\/j.clnu.2016.05.010_bib6","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.drudis.2012.02.001","article-title":"Myostatin: more than just a regulator of muscle mass","volume":"17","author":"Argil\u00e9s","year":"2012","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clnu.2016.05.010_bib7","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/j.clnu.2016.05.010_bib8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.cell.2010.07.011","article-title":"Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival","volume":"142","author":"Zhou","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.clnu.2016.05.010_bib9","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s13539-011-0049-z","article-title":"Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance","volume":"2012","author":"Busquets","year":"2012","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1042\/BJ20112024","article-title":"Myostatin is a novel tumoral factor that induces cancer cachexia","volume":"446","author":"Lokireddy","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.clnu.2016.05.010_bib11","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","article-title":"Cancer cachexia: understanding the molecular basis","volume":"14","author":"Argil\u00e9s","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clnu.2016.05.010_bib12","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1097\/MCO.0000000000000236","article-title":"Protein anabolic resistance in cancer: does it really exist?","volume":"19","author":"Engelen","year":"2016","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2016.05.010_bib13","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1093\/annonc\/mdv271","article-title":"High anabolic potential of essential amino acid mixtures in advanced nonsmall cell lung cancer","volume":"26","author":"Engelen","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnu.2016.05.010_bib14","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1002\/jcsm.12029","article-title":"Effects of oral meal feeding on whole body protein breakdown and protein synthesis in cachectic pancreatic cancer patients","volume":"6","author":"van Dijk","year":"2015","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib15","article-title":"Protein breakdown in cancer cachexia","author":"Sandri","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.clnu.2016.05.010_bib16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1006\/bbrc.2000.2462","article-title":"DNA fragmentation occurs in skeletal muscle during tumor growth: a link with cancer cachexia?","volume":"270","author":"van Royen","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clnu.2016.05.010_bib17","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.semcdb.2015.09.009","article-title":"Impaired regeneration: a role for the muscle microenvironment in cancer cachexia","volume":"54","author":"Talbert","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.clnu.2016.05.010_bib18","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/MCO.0000000000000164","article-title":"Muscle wasting in cancer: the role of mitochondria","volume":"18","author":"Argil\u00e9s","year":"2015","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/j.clnu.2016.05.010_bib19","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1002\/jcb.20246","article-title":"Tumor-host interactions","volume":"93","author":"Tisdale","year":"2004","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.clnu.2016.05.010_bib20","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/SPC.0b013e3283311d09","article-title":"The role of cytokines in cancer cachexia","volume":"3","author":"Argil\u00e9s","year":"2009","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2016.05.010_bib21","first-page":"1315","article-title":"Both AP-1 and NF-kappaB seem to be involved in tumour growth in an experimental rat hepatoma","volume":"29","author":"Moore-Carrasco","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clnu.2016.05.010_bib22","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1016\/j.febslet.2005.02.017","article-title":"Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats","volume":"579","author":"Barreiro","year":"2005","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clnu.2016.05.010_bib23","doi-asserted-by":"publisher","first-page":"E410","DOI":"10.1152\/ajpendo.00039.2012","article-title":"JAK\/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia","volume":"303","author":"Bonetto","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnu.2016.05.010_bib24","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.celrep.2012.03.014","article-title":"Mouse skeletal muscle fiber-type-specific macroautophagy and muscle wasting are regulated by a Fyn\/STAT3\/Vps34 signaling pathway","volume":"1","author":"Yamada","year":"2012","journal-title":"Cell Rep"},{"key":"10.1016\/j.clnu.2016.05.010_bib25","doi-asserted-by":"publisher","first-page":"E1042","DOI":"10.1152\/ajpendo.00410.2012","article-title":"Muscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK","volume":"304","author":"White","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.clnu.2016.05.010_bib26","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.clnu.2016.05.010_bib27","doi-asserted-by":"publisher","first-page":"30107","DOI":"10.1074\/jbc.M705325200","article-title":"The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor","volume":"282","author":"Greer","year":"2007","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.clnu.2016.05.010_bib28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1756-9966-31-81","article-title":"Expression of TRAF6 and ubiquitin mRNA in skeletal muscle of gastric cancer patients","volume":"31","author":"Sun","year":"2012","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.clnu.2016.05.010_bib29","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1002\/jcp.22821","article-title":"TWEAK causes myotube atrophy through coordinated activation of ubiquitin-proteasome system, autophagy, and caspases","volume":"227","author":"Bhatnagar","year":"2012","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.clnu.2016.05.010_bib30","first-page":"1239","article-title":"The AP-1\/NF-kappaB double inhibitor SP100030 can revert muscle wasting during experimental cancer cachexia","volume":"30","author":"Moore-Carrasco","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clnu.2016.05.010_bib31","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/379739a0","article-title":"Characterization of a cancer cachectic factor","volume":"379","author":"Todorov","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2016.05.010_bib32","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1054\/bjoc.2001.1830","article-title":"Proteolysis-inducing factor is expressed in tumours of patients with gastrointestinal cancers and correlates with weight loss","volume":"84","author":"Cabal-Manzano","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnu.2016.05.010_bib33","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1158\/1078-0432.CCR-07-0946","article-title":"Is there a human homologue to the murine proteolysis-inducing factor?","volume":"13","author":"Wieland","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clnu.2016.05.010_bib34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1098-1128(199905)19:3<223::AID-MED3>3.0.CO;2-N","article-title":"The role of cytokines in cancer cachexia","volume":"19","author":"Argil\u00e9s","year":"1999","journal-title":"Med Res Rev"},{"key":"10.1016\/j.clnu.2016.05.010_bib35","first-page":"471","article-title":"Interleukin-15 decreases proteolysis in skeletal muscle: a direct effect","volume":"16","author":"Busquets","year":"2005","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clnu.2016.05.010_bib36","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1054\/bjoc.2000.1299","article-title":"Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats","volume":"83","author":"Carb\u00f3","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clnu.2016.05.010_bib37","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0304-4165(00)00188-4","article-title":"Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control","volume":"1526","author":"Carb\u00f3","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clnu.2016.05.010_bib38","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.febslet.2004.05.066","article-title":"Interleukin-15 is able to suppress the increased DNA fragmentation associated with muscle wasting in tumour-bearing rats","volume":"569","author":"Figueras","year":"2004","journal-title":"FEBS Lett"},{"key":"10.1016\/j.clnu.2016.05.010_bib39","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s13539-014-0154-x","article-title":"Cachexia: a problem of energetic inefficiency","volume":"5","author":"Argil\u00e9s","year":"2014","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib40","doi-asserted-by":"publisher","first-page":"133","DOI":"10.18632\/aging.100436","article-title":"Disruption of MEF2C signaling induced skeletal muscle wasting","volume":"4","author":"Shum","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.clnu.2016.05.010_bib41","first-page":"15","article-title":"Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia","volume":"27","author":"Constantinou","year":"2011","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.clnu.2016.05.010_bib42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3892\/ijo.2013.1998","article-title":"Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia","volume":"43","author":"Tzika","year":"2013","journal-title":"Int J Oncol"},{"key":"10.1016\/j.clnu.2016.05.010_bib43","doi-asserted-by":"publisher","first-page":"e33426","DOI":"10.1371\/journal.pone.0033426","article-title":"Increase in muscle mitochondrial biogenesis does not prevent muscle loss but increased tumor size in a mouse model of acute cancer-induced cachexia","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clnu.2016.05.010_bib44","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","article-title":"Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?","volume":"1830","author":"Fontes-Oliveira","year":"2013","journal-title":"Biochim Biophys Acta Gen Subj"},{"key":"10.1016\/j.clnu.2016.05.010_bib45","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.biocel.2013.04.014","article-title":"Bladder cancer-induced skeletal muscle wasting: disclosing the role of mitochondria plasticity","volume":"45","author":"Padr\u00e3o","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.clnu.2016.05.010_bib46","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.yjmcc.2012.08.001","article-title":"Mitochondrial biogenesis and fragmentation as regulators of protein degradation in striated muscles","volume":"55","author":"Romanello","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clnu.2016.05.010_bib47","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbamcr.2011.11.003","article-title":"Multitasking in the mitochondrion by the ATP-dependent Lon protease","volume":"1823","author":"Venkatesh","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.clnu.2016.05.010_bib48","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2044-5040-2-14","article-title":"IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin\/+ mouse","volume":"2","author":"White","year":"2012","journal-title":"Skelet Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib49","doi-asserted-by":"publisher","first-page":"R393","DOI":"10.1152\/ajpregu.00716.2007","article-title":"Interleukin-6 and cachexia in ApcMin\/+ mice","volume":"294","author":"Baltgalvis","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.clnu.2016.05.010_bib50","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/med.20010","article-title":"Cross-talk between skeletal muscle and adipose tissue: a link with obesity?","volume":"25","author":"Argil\u00e9s","year":"2005","journal-title":"Med Res Rev"},{"key":"10.1016\/j.clnu.2016.05.010_bib51","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A\u00a0switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.clnu.2016.05.010_bib52","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature13528","article-title":"Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia","volume":"513","author":"Kir","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clnu.2016.05.010_bib53","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13539-011-0027-5","article-title":"The cachexia score (CASCO): a new tool for staging cachectic cancer patients","volume":"2","author":"Argil\u00e9s","year":"2011","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib54","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clnu.2016.05.010_bib55","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0031-1299694","article-title":"Exercise training decreases adipose tissue inflammation in cachectic rats","volume":"44","author":"Lira","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/j.clnu.2016.05.010_bib56","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/SPC.0000000000000170","article-title":"The therapeutic potential of exercise to treat cachexia","volume":"4","author":"Lira","year":"2015","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnu.2016.05.010_bib57","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s13539-012-0096-0","article-title":"Cancer cachexia prevention via physical exercise: molecular mechanisms","volume":"4","author":"Gould","year":"2013","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib58","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/jcsm.12055","article-title":"Exercise for cancer cachexia in adults: executive summary of a Cochrane Collaboration systematic review","volume":"6","author":"Grande","year":"2015","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib59","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-016-3144-z","article-title":"Anamorelin (ONO-7643) in Japanese patients with non-small cell lung cancer and cachexia: results of a randomized phase 2 trial","author":"Takayama","year":"2016","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnu.2016.05.010_bib60","doi-asserted-by":"publisher","first-page":"A7622","DOI":"10.1200\/jco.2010.28.15_suppl.7622","article-title":"Effect of ALD518, a humanized anti-IL-6 antibody, on lean body mass loss and symptoms in patients with advanced non-small cell lung Cancer (NSCLC): results of a phase II randomized, double-blind safety and efficacy trial","volume":"28","author":"Rigas","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clnu.2016.05.010_bib61","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s13539-011-0034-6","article-title":"The selective androgen receptor modulator GTx- 024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial","volume":"2","author":"Dalton","year":"2011","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib62","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","article-title":"The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats","volume":"5","author":"P\u00f6tsch","year":"2014","journal-title":"J\u00a0Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnu.2016.05.010_bib63","doi-asserted-by":"publisher","first-page":"6725","DOI":"10.1158\/0008-5472.CAN-04-0425","article-title":"Anticachectic effects of formoterol: a drug for potential treatment of muscle wasting","volume":"64","author":"Busquets","year":"2004","journal-title":"Cancer Res"}],"container-title":["Clinical Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561416301042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0261561416301042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,8]],"date-time":"2019-09-08T22:56:56Z","timestamp":1567983416000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0261561416301042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0261561416301042"],"URL":"https:\/\/doi.org\/10.1016\/j.clnu.2016.05.010","relation":{},"ISSN":["0261-5614"],"issn-type":[{"value":"0261-5614","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The 2015 ESPEN Sir David Cuthbertson lecture: Inflammation as the driving force of muscle wasting in cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnu.2016.05.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.","name":"copyright","label":"Copyright"}]}}